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MRI Findings of Primary CNS
Lymphoma in 26 Immunocompetent
Patients
Objective: To record the MR imaging features of primary central nervous sys-
tem lymphoma (PCNSL) and compare these features in monofocal and multifocal
disease.
Materials and Methods: Twenty-one cases of monofocal disease were com-
pared to five cases of multifocal disease. All patients were examined by non-
enhanced and contrast-enhanced MRI. Tumor location, tumor size, signal intensi-
ty, enhancement characteristics, age distribution, peritumoral edema, cystic
changes, and the presence of calcifications were assessed. The MRI features
were compared between the monofocal and multifocal disease cases.  
Results: The 26 cases, including both the monofocal and multifocal cases,
exhibited 37 lesions. Contrast-enhanced images showed variable enhancement
patterns: homogeneous enhancement (33 lesions), ring-like enhancement (2),
and ‘open-ring-like’ enhancement (2). The ‘notch sign’ was noted in four of 33
homogeneously enhancing lesions. One case of hemorrhage and three cases of
cystic formation were observed. Intra-tumoral calcification was not found. The
frontal lobe, the corpus callosum and the basal ganglia were commonly affected
in both the monofocal and multifocal groups. Tumor size differed significantly
between the two groups (t = 3.129, p < 0.01) and mildly or moderately enhanced
lesions were more frequently found in the monofocal group (p < 0.05). There was
no statistical difference between perifocal edema (p > 0.05) and the signal char-
acteristics (p > 0.05) between the two groups. 
Conclusion: Our data show that PCNSL has a variable enhancement pattern
on MR images. We first reported two lesions with an ‘open-ring’ enhancement as
well as four cases with a ‘notch sign’. Monofocal PCNSL cases typically have
larger sized tumors with mild or moderate enhancement.
rimary central nervous system lymphoma (PCNSL) is a rare disease,
accounting for 6% of all intracranial malignant tumors and for 1-2% of
all lymphomas (1-3). The incidence of PCNSL has recently been on the
rise, both in immunocompromised and immunocompetent populations (4, 5). A
common characteristic of PCNSL is multiplicity (2, 3, 6-11). 
Unlike most other brain tumors, radical surgical excision of PCNSLs is not
warranted because the lesions are highly infiltrative (12). Even partial tumor resection
appears to be a negative prognostic factor (13). PCNSL is a chemosensitive and
radiosensitive tumor and an early diagnosis may shift the treatment from extensive
surgery to radiotherapy (14). The accurate diagnosis of a PCNSL is crucial for the
treatment and prognosis of the patient. 
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Pprevious studies (1-3, 14-18). But, previous reports have
not yet systematically compared the different imaging
features of monofocal and multifocal PCNSLs. This
comparison would be helpful for the differential diagnosis
and prediction of clinical prognosis to compare monofocal
and multifocal PCNSLs (19). Therefore, this study reviews
26 cases of PCNSL in immunocompetent patients with the
goal (a) of identifying the clinical and neuroradiological
features and (b) to compare the MRI features of PCNSL in
cases of monofocal and multifocal disease. 
MATERIALS AND METHODS
A retrospective review of brain tumors in the pathology
archives of our institution, from 1996 to 2007, revealed 26
cases of PCNSL. Only patients without a history of
acquired immunodeficiency syndrome or other congenital
immunodeficiency disorders were included in the study.
This retrospective study was performed with the approval
of the review board and ethics committee of our institu-
tion. 
The evaluated patient group consisted of twelve women
and fourteen men ranging between 19 and 73 years of age
(average 51.5 ± 14.9 years) at the time of observation.
Both non-enhanced and contrast-enhanced MR images
were acquired for all patients. Twenty-one scans were
performed at 1.5T, whereas five scans were performed at
0.5T.
The MR images at 1.5T (Horizontal, GE Medical
Systems, Milwaukee, WI) were acquired with a slice
thickness of 8 mm. Axial pre-contrast spin echo (SE) T1
weighted image (WI) were obtained in all patients.
Additional pre-contrast scans were available for some
patients: axial SE T2WI (18 patients) or axial fluid attenu-
ated inversion recovery sequence (FLAIR) (19 patients) so
that all 26 patients had at least a T2WI or FLAIR sequence;
coronal pre-contrast SE T1WI and T2WI (6 patients).
Subsequently, an axial gadolinium-diethylenetriaminepen-
taacetate (Gd-DTPA)-enhanced SE T1WI was obtained in
all patients. An additional coronal Gd-DTPA-enhanced SE
T1WI was obtained in 12 patients; whereas, a sagittal
enhanced SE T1WI was obtained in 14 patients.
At 0.5T (Signa Contour, GE Medical Systems,
Milwaukee, WI), MR images were acquired at a slice
thickness of 8 mm. Axial SE T1WI and T2WI were
obtained before contrast medium administration.
Subsequently, axial and sagittal Gd-DTPA-enhanced SE
T1WI images were obtained. 
CT (HighSpeed, GE Medical Systems, Milwaukee, WI)
scans were performed in thirteen patients by 8 mm thick
axial plain scan images. Additionally, axial contrast-
enhanced images were obtained in three patients.
Two experienced radiologists independently reviewed
and analyzed the images retrospectively. All scans were
reviewed according to their location, including deep or
superficial location in the brain, size, margin, and the
characteristics of signal intensity. The presence of calcifica-
tions, cystic or necrotic changes, hemorrhage, and charac-
teristics of enhancement were also examined. The presence
of calcifications was confirmed on non-enhanced CT scans,
if available. Cystic tumor components were defined as
areas, which appeared hypointense on T1WI, hyperintense
on T2WI and hypointense on FLAIR sequences.
Hemorrhage was defined as areas that appeared hyperin-
tense on both T1WI and T2WI. A ‘notch sign’ was defined
as an abnormally deep depression at the tumor margin,
whereas ‘open-ring’ enhancement was defined as when the
enhanced ring was not closed. 
The degree of edema was judged as follows: a mean
diameter of peritumoral edema of less than 10 mm was
graded as mild edema, a mean diameter of 11-20 mm as
moderate edema, and a mean diameter of more than 20
mm as marked edema.
In the study, the degree of contrast enhancement of the
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Table 1. Location of Lesions
Location Monofocal Group Multifocal Group  Total
Corpus callosum 4 4 08
Frontal 6 4 10
Cerebellum 3 3 06
Temporal-parietal  1 01
Temporal 3 03
Sella 1 01
Basal ganglia 2 4 06
Brainstem  1 01
Cerebropontine angle 1 01
Table 2. Edema Grade of Lesions
Grade of Edema Monofocal Group Multifocal Group Total
None 02 02
Mild 11 12 23
Moderate 04 04 08
Marked 04 04
Table 3. Enhancement Grade of Lesions 
Enhancement Grade
Monofocal  Multifocal 
Group Group
Total
Mild 03 02 05
Moderate 05 02 07
Marked 13 12 25tumor (dCt) was calculated according to literature findings
(20), a dCt less than 25 was graded mild enhancement, a
dCt between 25-50 was graded as moderate enhancement,
and a dCt of more than 50 was graded as marked enhance-
ment.
Histopathology and immunohistochemistry assessments
were performed in all cases. For an immunohistochemistry
assessment, paraffin sections were treated with monoclonal
antibodies against common leukocyte antigen (CLA) and
human B-lymphocytes (mAb L26). 
The statistical analyses were performed by the statisti-
cian of our institution. In brief, a student t-test was used to
test the difference in tumor size between monofocal and
multifocal disease; whereas, the Chi-square test was used
for testing for the difference in peritumoral edema,
enhancement degree and signal characteristics. Statistical
significance was set at a p-value < 0.05.  
RESULTS
Clinical Findings
In the cohort, none of the patients had a history of
acquired immunodeficiency syndrome or other congenital
immunodeficiency disorders. The clinical signs at the time
of presentation were disturbance of intellectual functions
and behavioral problems in 17 patients (65%), hemiplegia
in 12 (46%), signs of acute intracranial hypertension in
eight (31%), cranial nerve deficits in seven (27%), and
cerebellar syndromes or epileptic seizures in five (19%).
The average duration of clinical symptoms at the time of
diagnosis was 4.3 months. 
Ten cases (39%) were correctly diagnosed as PCNSL.
On the other hand, four cases were preoperatively
misdiagnosed as gliomas, five cases were misdiagnosed as
metastatic tumors, and three cases were misdiagnosed as
meningiomas. The four remaining cases were mistakenly
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Fig. 1. Images of 52-year-old man with
lymphoma of left basal ganglia including
plain CT image (A), axial T1-weighted
image (B), T2-weighted image (C),
FLAIR (D) and postcontrast axial T1-
weighted image (E). Abnormally deep
depression at tumor margin (notch sign)
(arrow) was found on post-contrast axial
T1-weighted image and plain CT image. 
DEdiagnosed as an astrocytoma, hemangioblastoma, glomus
jugulare tumor, or craniopharyngioma. 
Histopathology and Immunohistochemistry
The histological diagnosis could be ascertained in each
case by a positive CLA reaction. Based on the Kiel classifi-
cation, all lymphomas in the cohort were of B-cell origin.
Some were further classified into subtypes: diffuse large
cell (13 patients), immunoblastic (5), lymphocytic (3), small
cleaved (2), or diffuse mixed (3). 
Neuroradiological Findings 
In our cohort, five patients (19%) had multifocal lesions,
which added up to a total of 37 lesions. The neuroradiolog-
ical appearances of PCNSL were therefore classified as two
groups: monofocal and multifocal disease. 
Monofocal Group
The monofocal group included 21 patients (21 of 26, 11
women and 10 men) that had solitary lesions. The mean
age was 53 ± 15.6 years (range 19-71 years). The lesions
were primarily located in the frontal lobe (n = 6), the
corpus callosum (n = 4), the temporal lobe (n = 3) and the
cerebellum (n = 3) (Table 1). Eighteen lesions were located
deep within the brain, whereas the other three were
located superficially. The mean size of the lesions was 39
± 1.71 cm (range 2.0-7.0 cm). All lesions in the corpus
callosum involved the genu or splenium. On T1WI
sequences, all lesions appeared to be hypointense. On
T2WI or on FLAIR sequences, 14 lesions appeared to be
hyperintense, whereas the remaining seven tumors
appeared to be isointense. 
Perilesional edema was present in 19 cases of monofocal
Zhang et al.
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Fig. 2. Images of 71-year-old woman
with lymphoma of left temporal lobe
including pre-contrast axial T1-weighted
image (A), post-contrast axial T1-
weighted image (B). ‘Notch sign’ (arrow)
was found on post-contrast T1-weighted
image. 
AB
Fig. 3. Images of 49-year-old woman with primary central nervous system lymphoma including pre-contrast axial T1-weighted image
(A), pre-contrast T2-weighted image (B), post-contrast axial T1-weighted image (C). ‘Notch sign’ (arrow) was found after contrast
injection. 
ABCtumors, 11 cases of which showed mild, four showed
moderate and four showed marked edema. The other two
cases of monofocal tumors showed no edema (Table 2).
The degree of edema was not consistent with tumor size;
some small lesions showed disproportionately marked
edema. Lesions in the posterior fossa had no edema or
mild edema, while moderate or marked perifocal edema
was found in supratentorial lesions. 
Cystic changes were found in two cases. The mean size
of the two tumors was 2.8 cm (3.0 cm and 2.6 cm). A small
round 2 mm diameter cyst was found in one case, whereas
a stripy cyst formation was found for the other case. A
histologically confirmed subacute hemorrhage, appearing
as a patchy hyperintense signal on T1WI, was found in one
tumor in the sellar region. 
Monofocal lesions showed a variable contrast enhance-
ment ranging from mild (n = 3), to moderate (n = 5), and to
marked enhancement (n = 13) (Table 3). The enhancement
was homogeneous in 19 cases. In three of these 19 cases,
an abnormally deep depression was found at the tumor
margin, which we called ‘notch sign’ (Figs. 1-3). A ring-like
enhancement was found in two cases in which the ring was
not closed and it was called ‘open-ring’ enhancement (Figs.
4, 5). The open-ring like enhancement was thick and not
uniform. 
Of the 21 patients with monofocal lesions, ten received a
plain CT scan. Furthermore, of these ten patients three had
an available enhanced CT scan. All 10 lesions appeared
slightly hyperdense compared to the normal brain. A
marked and homogeneous enhancement was found in all
three cases available with the enhanced CT scan.
Multifocal Group
Five patients (19%, 1 woman, 4 men) had multifocal
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Fig. 4. Images of 57-year-old man with lymphoma of right frontal lobe including plain CT image (A), contrast CT image (B), axial T1-
weighted image (C), FLAIR (D), postcontrast axial T1-weighted image (E) and sagittal T1-weighted image (F). On plain CT image; lesion
was hyperdense. ‘Open-ring’ enhancement (arrows) was found and was characterized as thick and not uniform.
DEFlesions. The mean age of these five patients was 45.8 ±
9.5 years (range 36-61 years). One patient had two
lesions, three patients had three lesions, and one patient
had five lesions, for a total of 16 lesions. The mean lesion
size was 2.2 ± 1.36 cm (range 0.5-6.2 cm). Two cases
involved both sides of the tentorium, one case with two
lesions involved the cerebellar hemispheres bilaterally,
whereas the other two cases had only supratentorial
lesions.  The lesions involved the frontal lobe (n = 4),
corpus callosum (n = 4), basal ganglia (n = 4), cerebellum
(n = 3) and the brainstem (n = 1) (Table 1). Moreover, the
lesions involved deep white or gray matter in the brain (n
= 12) or a superficial location (n = 4). Multifocal lesions
showed a hypointense signal on T1WI and a slightly
hyperintense signal on T2WI or FLAIR imaging.
Of the 16 lesions, 12 had mild peritumoral edema,
whereas the remaining four moderate edema (Table 2). A
small round cyst with a 1.5 mm in diameter was found in
one case.
Following the contrast agent (Gd-DTPA) injection, 12
lesions in four patients showed marked enhancement,
whereas four lesions in two patients showed mild or
moderate enhancement (Table 3). Enhancement was
homogeneous in 14 lesions and ring-like in two lesions.
The lesion with the small cyst formation showed heteroge-
neous enhancement. One lesion with a ‘notch sign’ was
found. The ring of enhancement was completely closed in
the two cases with ring-like enhancement. The co-existence
of ring-like and homogeneous enhancement as well as of a
‘notch-sign’ and homogeneous enhancement was found in
one case. No subependymal spread was found in the
group.
One patient received both a plain and enhanced CT scan.
The lesions showed hyperattenuation and moderate
homogeneous enhancement after contrast injection. 
Statistical Analysis
Tumor sizes in the monofocal group were significantly
larger than the multifocal group (p = 0.00355). Lesions
with mild or moderate enhancement were more frequent
in the cases of monofocal disease (p = 0.017). There were
no significant differences for perifocal edema (p = 0.054)
and signal changes (p = 0.164) between the two groups. 
DISCUSSION
This study involve the evaluation of the MRI findings of
26 histologically confirmed cases of PCNSL in immuno-
competent patients and compares the imaging characteris-
tics of monofocal disease with those of multifocal disease.
In principle, our study confirms previous results regarding
the appearance of PCNSL on MR images. However, we
further detailed two characteristic enhancement features of
the tumors that might be helpful in the differential diagno-
sis.
The mean age at diagnosis in this study was 51.5 ± 14.9
years, which is lower than in previously reported data (6,
21). In other publications, PCNSL usually occurred in the
sixth decade (15, 22). There was no significant difference
for mean age between monofocal and multifocal
lymphomas. 
Male predominance is generally recognized at a ratio of
up to 1.2-1.7 (23, 24) in PCNSL. Our data confirms this
with a ratio of male cases to female cases of 1.3.
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Fig. 5. Images of 56-year-old woman with lymphoma involving frontal lobe bilaterally including pre-contrast axial T1-weighted image (A),
pre-contrast T2-weighted image (B) and post-contrast axial T1-weighted image (C). ‘Open-ring’ enhancement (arrow) was found and
was characterized as thick and not uniform.
ABCMultiplicity of PCNSL is a common characteristic (2, 3).
The highest reported number of lesions can be as high as
eight (10). We present one case with five lesions. The
frequency of the multifocal tumor shows great variation
(range 0-50%) in immunocompetent patients (8, 11). 
In our patient cohort, most lesions affected the frontal
lobe, the corpus callosum, and the basal ganglia, which is
consistent with previous studies (8, 16). No statistical
difference was found for tumor location between monofo-
cal and multifocal disease (p > 0.05). The classical ‘mirror
image’ or ‘butterfly pattern’ - caused by lesions involving
the genu or splenium in a symmetrical pattern - was found
in four cases. We located 24% (9 of 37) of the lesions in
the posterior fossa, which is higher than previously
reported (12%) (7, 8). PCNSL located both above and
below the tentorium is reported to be rare (11), and consis-
tently, only 8% of the patients (2 of 26) in our study
involved both sides of the tentorium.
An image analysis showed that the lesion size for
monofocal disease is significantly larger than for multifocal
disease at the time of diagnosis (3.8 cm versus 2.2 cm),
which is consistent with previously reported results (3.9 cm
versus 1.64 cm) (7, 9). The reason for the difference in
lesion size is unclear. We hypothesize that multifocal
tumors present symptoms at an earlier stage (and thus at a
smaller size), because multiple lesions are likely to have a
larger effect than single lesions. 
Mild or moderate peritumoral edema is a common
feature of PCNSL (11); it is generally less pronounced than
in metastases or high grade gliomas (25). The fact that
marked peritumoral edema is uncommon is probably due
to the infiltrative nature of the tumor (3, 26). Our data
support this assessment, with 84% of the evaluated lesions
with mild to moderate edema. However, we found two
lesions without edema and this is consistent with previous
reports (2, 27). We also report four lesions with marked
edema which were not reported previously as well.
Contrary to Coulon’s study, which reports lesser edema in
the multifocal group than in the monofocal group (3), we
found no statistical significance between the groups. 
On pre-contrast MR images PCNSL is known to appear
as hypo- or iso-intense on T1WI, and hyper- or iso-intense
on T2WI (3, 15-17). Consistent with and the findings
above, we did not detect a statistical difference between
the monofocal and the multifocal groups. In contrast, the
enhancement after injection of Gd-DTPA is known to be
variable (9, 15, 17), and in multifocal disease, can even
enhance to a different degree within the same patient (11,
28); even tumors without any enhancement were reported
(9-11, 28). In our cohort, all the lesions showed enhance-
ment, but the degree and pattern was variable. Most
lesions (25 of 37) showed marked enhancement, while the
rest (12 of 37) exhibited mild or moderate enhancement.
Mild or moderate enhancement was more frequent in
monofocal disease. 
As for the enhancement pattern, our data and previous
studies concur in that enhancement is most commonly
homogeneous (14-18). Ring-like enhancement can be
found in immunodeficient patients, but is rare in immuno-
competent patients (7, 17). Lesions with gyral-like and a
radial enhancement pattern has been reported previously
(3, 27, 29). To the best of our knowledge, this study is the
first to report two specific enhancement patterns: 1) Two
tumors showed an open-ring enhancement, which is
considered highly specific for atypical brain demyelination
(30, 31). However, the ring of enhancement is thin and
uniform in brain demyelination, whereas in PCNSL, the
ring is thick and not uniform. 2) We report four homoge-
neously enhanced tumors with a ‘notch sign’. The findings
suggest that PCNSL should be suspected when lesions
show these two specific enhancement patterns. Thus, the
two features may be helpful for the differential diagnosis of
brain tumors. The specificity will need to be tested in a
larger series of brain tumors.
The typical CT finding of PCNSL is that of a primarily
iso- or hyperdense space-occupying mass with marked
homogeneous enhancement (7, 8). In this study, all lesions
(n = 12) with available CT data showed these features. 
Furthermore, there are several uncommon findings for
PCNSL in immunocompetent patients. First, cystic changes
are a very uncommon finding in PCNSL in immunocompe-
tent patients and when present, are usually small single
cysts (3, 11, 28). In the present patient population, three
small intratumoral cysts were present (average diameter 3
mm), which is in line with previously reported data (11).
Secondly, intratumoral calcifications are rare in PCNSL,
and to our knowledge, only two cases of PCNSL with
calcification before treatment have been reported (3, 11).
Therefore, calcifications must be considered as a useful
imaging characteristic to differentiate PCNSL from other
intracranial tumors that have a tendency to calcify.
However, calcifications are more frequently found after
the patient has undergone chemotherapy or radiation
treatment (3, 14). Lastly, very few cases with intratumoral
hemorrhage have been reported in the literature (3, 7, 27).
Tumors with hemorrhage have a wide distribution. Our
study includes one lesion with chronic hemorrhage in the
sellar region.
There are some limitations in the study. In our cohort,
only 10 patients (9 with monofocal lesion, 1 with multifo-
cal lesion) had complete follow-up data; therefore, the
difference in clinical prognosis between the two groups
MRI Findings of Primary CNS Lymphoma
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CT was 8 mm, which was thicker compared with the 5 mm
slice thickness usually used in many hospitals. The differ-
ence in slice thickness may affect the detection rate of
small parenchymal lesions. Although, to the best of our
knowledge, this is the first report of the ‘notch sign’ and
‘open ring sign’ in PCNSL and the specificity for the differ-
ential diagnosis needs to be tested in a large series of brain
tumors. 
In summary, our study of the MR imaging data of 26
cases of PCNSL in immunocompetent patients concurs
with previously described patient populations. Tumors are
mostly present in the 5th or 6th decade and they can be
monofocal or multifocal. Lesions are typically located in
the frontal lobe, corpus callosum, or the basal ganglia, and
may present with a ‘butterfly sign’. On pre-contrast MR
images tumors usually appear hypo- or iso-intense on
T1WI and hyperintense on T2WI. Further, the tumors are
typically surrounded by edema and post Gd-DTPA
enhancement is commonly homogeneous but variable. To
the best of our knowledge, we are the first to report an
‘open-ring’ and a ‘notch sign’ as enhancement patterns.
Calcifications, cyst formations, and hemorrhage are rare
findings and are rather indicative of other diseases.
Considering the variable appearance of PCNSL in either
monofocal or multifocal disease, awareness of the tumor
appearance spectrum reviewed in this study would be
helpful for a correct diagnosis. 
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